Longfei Fan
Bengbu, 233000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exosomal IGFALS as a Prognostic Biomarker in Hepatocellular Carcinoma: Associations with Immune Infiltration and Clinical Outcomes.
Journal: Molecular and cellular probes
Published: August 20, 2025
Exosomal IGFALS as a prognostic biomarker in hepatocellular Carcinoma: Associations with immune infiltration and clinical outcomes.
Journal: Molecular and cellular probes
Published: August 20, 2025
HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance.
Journal: Translational oncology
Published: May 05, 2024
LARS1 is a Prognostic Biomarker and Exhibits a Correlation with Immune Infiltrates in Hepatocellular Carcinoma.
Journal: International journal of general medicine
Published: February 08, 2024
Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma.
Journal: Translational oncology
Published: July 15, 2023
Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: January 14, 2023
Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis.
Journal: Toxicology mechanisms and methods
Published: May 20, 2022
The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.
Journal: International journal of general medicine
Published: June 10, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026